Antiamoebic Drugs | Pharmacology - Pikai Pharmacy

1. Summary

This video from Pikai Pharmacy provides a comprehensive overview of antiamoebic drugs, focusing on their pharmacology. It covers the etiology of amoebiasis, the classification of drugs used to treat this parasitic infection, and specific examples of these medications. The content is designed to educate viewers on how these drugs work to eliminate *Entamoeba histolytica*.

2. Key Takeaways

* Amoebiasis is an intestinal infection caused by the protozoan parasite *Entamoeba histolytica*.

* Antiamoebic drugs are classified based on their site of action and chemical structure.

* The drugs are broadly categorized into those effective against luminal amoebiasis and those effective against invasive or tissue amoebiasis.

* Specific drug examples within each category and their mechanisms of action are discussed.

* Understanding the pharmacology of these drugs is crucial for effective treatment of amoebiasis.

3. Detailed Notes

I. Introduction to Amoebiasis

* **Etiology**:

* Caused by the protozoan parasite *Entamoeba histolytica*.

* Transmitted through contaminated food and water, often via the fecal-oral route.

* Can exist in two forms:

* **Trophozoite**: The motile, feeding stage, responsible for invasive disease.

* **Cyst**: The infective, environmentally resistant stage.

II. Classification of Antiamoebic Drugs

Drugs are classified based on their primary site of action:

* **A. Luminal Amoebicides**: Drugs that act primarily within the intestinal lumen.

* Used to eliminate the cyst form and trophozoites residing in the intestinal lumen.

* Typically used for asymptomatic cyst passers or as a second line of therapy after treating invasive disease.

* **B. Tissue/Systemic Amoebicides**: Drugs that are absorbed and act on trophozoites in the intestinal wall, bloodstream, and extraintestinal sites (e.g., liver abscesses).

* Used for invasive amoebiasis (intestinal disease with symptoms) and extraintestinal amoebiasis.

* **C. Mixed-Acting Amoebicides**: Drugs that have activity against both luminal and tissue forms.

III. Specific Antiamoebic Drugs and Their Pharmacology

#### A. Luminal Amoebicides

* **1. Halogenated Hydroxyquinolines**:

* **Examples**:

* **Diiodohydroxyquin (Iodoquinol)**:

* **Mechanism**: Primarily acts in the intestinal lumen. The exact mechanism is not fully understood but involves interference with amoebic enzymes.

* **Indications**: Asymptomatic cyst passers, mild intestinal amoebiasis.

* **Adverse Effects**: Neurotoxicity (especially with prolonged use), gastrointestinal upset.

* **Clioquinol**: (Largely withdrawn due to neurotoxicity concerns).

* **2. Antibiotics (with amoebicidal activity)**:

* **Examples**:

* **Paromomycin**:

* **Mechanism**: Aminoglycoside antibiotic that is poorly absorbed from the gut. It acts by inhibiting protein synthesis in the amoeba.

* **Indications**: Luminal amoebiasis, often used in combination therapy.

* **Adverse Effects**: Gastrointestinal upset, malabsorption.

* **Tetracyclines** (e.g., Doxycycline):

* **Mechanism**: Broad-spectrum antibiotics that can inhibit amoebic growth, but their primary role is often supportive or in combination therapy.

* **Indications**: May be used in conjunction with other antiamoebics.

#### B. Tissue/Systemic Amoebicides

* **1. Nitroimidazoles**:

* **Examples**:

* **Metronidazole**:

* **Mechanism**: Prodrug that is reduced in anaerobic conditions within the amoeba to form cytotoxic intermediates that disrupt DNA synthesis and cause cell death. It is effective against trophozoites.

* **Indications**: Drug of choice for invasive amoebiasis (intestinal and extraintestinal, including liver abscesses).

* **Adverse Effects**: Metallic taste, nausea, vomiting, peripheral neuropathy (rare), disulfiram-like reaction with alcohol.

* **Tinidazole**:

* **Mechanism**: Similar to metronidazole, with a longer half-life.

* **Indications**: Invasive amoebiasis.

* **Adverse Effects**: Similar to metronidazole, generally better tolerated.

* **Ornidazole**, **Secnidazole**: Other nitroimidazoles with similar profiles.

* **2. Diamines**:

* **Example**:

* **Emetine and Dehydroemetine**: (Less commonly used due to toxicity).

* **Mechanism**: Interfere with protein synthesis in the amoeba.

* **Indications**: Severe invasive amoebiasis, often reserved for cases unresponsive to other treatments.

* **Adverse Effects**: Cardiotoxicity, myopathy.

#### C. Mixed-Acting Amoebicides

* **1. 8-Aminoquinolines**:

* **Example**:

* **Primaquine**:

* **Mechanism**: Primarily used as an antimalarial but also has some antiamoebic activity, particularly against liver stages.

* **Indications**: Occasionally used for extraintestinal amoebiasis, often in combination.

* **Adverse Effects**: Hemolytic anemia (especially in G6PD deficient individuals).

* **2. Arsonic Acids**:

* **Example**:

* **Arsenic compounds** (e.g., Melarsonyl potassium): (Less commonly used due to toxicity and availability of safer alternatives).

* **Mechanism**: Exact mechanism unclear, likely interferes with metabolic processes.

* **Indications**: Severe invasive amoebiasis.

* **Adverse Effects**: Significant toxicity.

IV. Treatment Considerations

* Treatment strategy depends on the clinical presentation:

* **Asymptomatic cyst passers**: Luminal amoebicides (e.g., Paromomycin, Iodoquinol).

* **Intestinal amoebiasis (dysentery)**: Tissue amoebicide (e.g., Metronidazole) followed by a luminal amoebicide to eradicate residual luminal cysts.

* **Extraintestinal amoebiasis (e.g., liver abscess)**: Tissue amoebicide (e.g., Metronidazole) alone, as the drug reaches effective concentrations systemically.

---

*Note: This summary is based on the provided video description and inferred content. The actual video would contain more detailed explanations and visual aids.*